GENERAL COMMENTARY article

Front. Microbiol., 30 July 2013

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 4 - 2013 | https://doi.org/10.3389/fmicb.2013.00214

Commentary on genetic mechanisms of antimicrobial resistance in bacteria from U.S. food animals: ESBLs are here

  • SR

    Steven Roach 1*

  • DW

    David Wallinga 2

  • 1. Food Animal Concerns Trust Chicago, IL, USA

  • 2. Keep Antibiotics Working, St. Paul MN, USA

While Frye and Jackson do a good job describing the common mechanisms of resistance found in food animals in the U.S., they err in stating that in the U.S. extended spectrum β-lactamases (ESBLs) “thus far have only been found in human and not food animal isolates.”

In fact, Wittum et al., in 2010 first reported the collection of Escherichia coli expressing CTX-M-type ESBLs in fecal isolates from healthy cattle at a livestock market and from a diagnostic isolate submitted to the Ohio Animal Disease Diagnostic Laboratory. Since then, CTX-M-type ESBLs have been found in E. coli collected from healthy dairy calves in the western U.S. (Davis et al., 2011) and from 5 of 20 dairy farms in Ohio (Mollenkopf et al., 2012); in clinical Salmonella enterica isolates from swine in Minnesota and from turkeys in 4 states (Wittum et al., 2012); in E. coli from swine finishing barns in Michigan and Ohio and in Klebsiella pneumoniae from swine in Illinois (Mollenkopf et al., 2013).

We are not aware of studies finding CTX-M-type ESBLs in isolates from broiler chickens, but a retail chicken meat E. coli isolate expressing CTX-M-type ESBLs from Pennsylvania has been reported (Doi et al., 2010). Given the situation in other livestock species and in other countries, we expect the lack of detection of CTX-M-type ESBLs in U.S. chicken isolates is more the result of lack of appropriate studies than a real absence of these on chicken farms. In addition to CTX-M-type ESBLs, the study of dairy calves in the western U.S. also found E. coli expressing OXA-type ESBLs (Davis et al., 2011).

References

  • 1

    DavisM. A.BesserT. E.OrfeL. H.BakerK. N.LanierA. S.BroschatS. L.et al. (2011). Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use. Appl. Environ. Microbiol. 77, 32933299. 10.1128/AEM.02588-10

  • 2

    DoiY.PatersonD. L.EgeaP.PascualA.López-CereroL.NavarroM. D.et al. (2010). Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin. Microbiol. Infect. 16, 3338. 10.1111/j.1469-0691.2009.03001.x

  • 3

    MollenkopfD. F.MireckiJ. M.DanielsJ. B.FunkJ. A.HenryS. C.HansenG. E.et al. (2013). Escherichia coli and Klebsiella pneumoniae producing CTX-M cephalosporinase from swine finishing barns and their association with antimicrobial use. Appl. Environ. Microbiol. 79, 10521054. 10.1128/AEM.03169-12

  • 4

    MollenkopfD. F.WeemanM. F.DanielsJ. B.AbleyM. J.MathewsJ. L.GebreyesW. A.et al. (2012). Variable within- and between-herd diversity of CTX-M cephalosporinase-bearing Escherichia coli isolates from dairy cattle. Appl. Environ. Microbiol. 78, 45524560. 10.1128/AEM.00373-12

  • 5

    WittumT. E.MollenkopfD. F.ErdmanM. M. (2012). Detection of Salmonella enterica isolates producing CTX-M Cephalosporinase in U.S. livestock populations. Appl. Environ. Microbiol. 78, 74877491. 10.1128/AEM.01682-12

  • 6

    WittumT. E.MollenkopfD. F.DanielsJ. B.ParkinsonA. E.MathewsJ. L.FryP. R.et al. (2010). CTX-M-type extended-spectrum β-lactamases present in Escherichia coli from the feces of cattle in Ohio, United States. Foodborne Pathog. Dis. 7, 15751579. 10.1089/fpd.2010.0615

Summary

Keywords

E. coli, Salmonella, Animals, ESBLs, antimicrobial, CTX-M

Citation

Roach S and Wallinga D (2013) Commentary on genetic mechanisms of antimicrobial resistance in bacteria from U.S. food animals: ESBLs are here. Front. Microbiol. 4:214. doi: 10.3389/fmicb.2013.00214

Received

28 June 2013

Accepted

09 July 2013

Published

30 July 2013

Volume

4 - 2013

Edited by

Henk Aarts, National Institute for Public Health and the Environment, Netherlands

Reviewed by

Axel Cloeckaert, Institut National de la Recherche Agronomique, France

Copyright

*Correspondence:

This article was submitted to Frontiers in Antimicrobials, Resistance and Chemotherapy, a specialty of Frontiers in Microbiology.

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics